Login / Signup

Consider TLR5 for new therapeutic development against COVID-19.

Chiranjib ChakrabortyAshish Ranjan SharmaManojit BhattacharyaGarima SharmaSang-Soo LeeGovindasamy Agoramoorthy
Published in: Journal of medical virology (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • toll like receptor
  • inflammatory response
  • immune response